Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PDR - Proliferative Diabetic Retinopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00347698
What this trial is testing

Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Asociación para Evitar la Ceguera en México
Not applicableStudy completedNCT07144865
What this trial is testing

Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection

Who this might be right for
Proliferative Diabetic Retinopathy
Bojie Hu 8
Large-scale testing (Phase 3)Study completedNCT01627977
What this trial is testing

Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy

Who this might be right for
Epiretinal MembraneMacular HoleProliferative Diabetic Retinopathy
Federal University of São Paulo 18
Large-scale testing (Phase 3)Ended earlyNCT05066230
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Non-proliferative Diabetic Retinopathy
Kodiak Sciences Inc 253
Not applicableStudy completedNCT03525899
What this trial is testing

Macular Hole After Diabetic Vitrectomy

Who this might be right for
Proliferative Diabetic RetinopathyMacular Holes
National Taiwan University Hospital 7
Testing effectiveness (Phase 2)UnknownNCT05642793
What this trial is testing

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Who this might be right for
Proliferative Diabetic Retinopathy
Peking University Third Hospital 80
Testing effectiveness (Phase 2)Study completedNCT02753400
What this trial is testing

Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Kubota Vision Inc. 24
Post-approval studies (Phase 4)UnknownNCT02005432
What this trial is testing

PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
University of Sao Paulo 31
Testing effectiveness (Phase 2)Study completedNCT01746563
What this trial is testing

Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyRetinal DiseasesEye Diseases+3 more
University of Sao Paulo 30
Not applicableStudy completedNCT01625598
What this trial is testing

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Who this might be right for
Diabetic Retinopathy
Digital Diagnostics, Inc. 600
Large-scale testing (Phase 3)Looking for participantsNCT07235085
What this trial is testing

Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Ocular Therapeutix, Inc. 930
Early research (Phase 1)Ended earlyNCT01589029
What this trial is testing

A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)

Who this might be right for
Proliferative Diabetic Retinopathy
PD Dr. med. Stephan Michels 6
Not applicableUnknownNCT05631054
What this trial is testing

Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients

Who this might be right for
Proliferative Diabetic RetinopathyPars Plana VitrectomyRisk Prediction Model
Tianjin Medical University Eye Hospital 250
Large-scale testing (Phase 3)Ended earlyNCT00170742
What this trial is testing

Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.

Who this might be right for
Proliferative Diabetic Retinopathy
Novartis 17
Not applicableStudy completedNCT02879422
What this trial is testing

Genetic Markers and Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
CHU de Reims 302
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236645
What this trial is testing

Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Not applicableUnknownNCT04103671
What this trial is testing

Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Non Proliferative Diabetic Retinopathy
Zhongshan Ophthalmic Center, Sun Yat-sen University 272
Large-scale testing (Phase 3)Study completedNCT01813773
What this trial is testing

Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study

Who this might be right for
Proliferative Diabetic Retinopathy
Ophthalmic Consultants of Long Island 20
Not applicableStudy completedNCT02995629
What this trial is testing

Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation

Who this might be right for
Proliferative Diabetic Retinopathy - High Risk
Wills Eye 40
Testing effectiveness (Phase 2)Study completedNCT02863354
What this trial is testing

Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Charles C Wykoff, PhD, MD 43
Next Page